The Neurobiology of Sleep and Wakefulness

Psychiatric Clinics of North America

Volumn 38, Issue 4, 2015, Pages 615-644

  Schwartz, Michael D ^a   Kilduff, Thomas S ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

EEG; Homeostasis; Hypocretin; Neurotransmitter; NREM sleep; REM sleep; Slow wave activity; Synchronization

Indexed keywords

ACETYLCHOLINE; ALPHA INTERMEDIN; CHOLECYSTOKININ OCTAPEPTIDE; DYNORPHIN; GALANIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HLA ANTIGEN CLASS 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; MELATONIN; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE Y; OREXIN A; OREXIN B; PROSTAGLANDIN D2; PROTEIN FOS; SEX HORMONE; SOMATOMEDIN C; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; 4 AMINOBUTYRIC ACID RECEPTOR; BIOGENIC AMINE; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE; OREXIN;

ADRENAL CORTEX; AROUSAL; BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN REGION; CATAPLEXY; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; EPIDEMIC ENCEPHALITIS; GABAERGIC SYSTEM; HOMEOSTASIS; HORMONE ACTION; HUMAN; NARCOLEPSY; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REM SLEEP; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; SUPRACHIASMATIC NUCLEUS; BRAIN; CHOLINERGIC NERVE CELL; NERVE TRACT; PHYSIOLOGY; SLEEP; WAKEFULNESS;

BIOGENIC MONOAMINES; BRAIN; CHOLINERGIC NEURONS; CIRCADIAN CLOCKS; GABAERGIC NEURONS; HUMANS; HYPOTHALAMIC HORMONES; MELANINS; NEURAL PATHWAYS; OREXINS; PITUITARY HORMONES; SLEEP; WAKEFULNESS;

EID: 84947488415     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2015.07.002     Document Type: Review

References (339)

1. Loomis A.L., Harvey E.N., Hobart G. Potential rhythms of the cerebral cortex during sleep. Science 1935, 81(2111):597-598.
2. Szymusiak R. Hypothalamic versus neocortical control of sleep. Curr Opin Pulm Med 2010, 16(6):530-535.
3. Siegel J.M. The neurobiology of sleep. Semin Neurol 2009, 29(4):277-296.
4. Rolls E.T., Inoue K., Browning A. Activity of primate subgenual cingulate cortex neurons is related to sleep. J Neurophysiol 2003, 90(1):134-142.
5. Rudolph M., Pospischil M., Timofeev I., et al. Inhibition determines membrane potential dynamics and controls action potential generation in awake and sleeping cat cortex. J Neurosci 2007, 27(20):5280-5290.
6. Brown R.E., Basheer R., McKenna J.T., et al. Control of sleep and wakefulness. Physiol Rev 2012, 92(3):1087-1187.
7. Saper C.B., Fuller P.M., Pedersen N.P., et al. Sleep state switching. Neuron 2010, 68(6):1023-1042.
8. Steriade M., McCormick D.A., Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science 1993, 262(5134):679-685.
9. Crunelli V., Hughes S.W. The slow (<1 Hz) rhythm of non-REM sleep: a dialogue between three cardinal oscillators. Nat Neurosci 2010, 13(1):9-17.
10. Bremer F. Cerveau "isole" et physiologie du sommeil. C R Soc Biol (Paris) 1935, 118:1235-1241.
11. Moruzzi G., Magoun H. Brainstem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol 1949, 1:455-473.
12. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005, 26(11):578-586.
13. Saper C.B., Chou T.C., Scammell T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001, 24(12):726-731.
14. Steriade M., McCarley R.W. Brain control of wakefulness and sleep 2005, Kluwer Academic/Plenum Publishers, New York.
15. Carter M.E., Yizhar O., Chikahisa S., et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010, 13(12):1526-1533.
16. Ito H., Yanase M., Yamashita A., et al. Analysis of sleep disorders under pain using an optogenetic tool: possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons. Mol Brain 2013, 6:59.
17. McGinty D., Szymusiak R. Neural control of sleep in mammals. Principles and practice of sleep medicine 2011, 76-91. Elsevier, St Louis (MO). 5th edition. J. Siegel (Ed.).
18. Van Dort C.J., Zachs D.P., Kenny J.D., et al. Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep. Proc Natl Acad Sci U S A 2015, 112(2):584-589.
19. Blanco-Centurion C., Gerashchenko D., Shiromani P.J. Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 2007, 27(51):14041-14048.
20. Batini C., Moruzzi G., Palestini M., et al. Persistent patterns of wakefulness in the pretrigeminal midpontine preparation. Science 1958, 128(3314):30-32.
21. Hess W.R. Über die Wechselbeziehungen zwischen psychischen und vegetativen Funktionen. Schweiz Arch Neurol Psychiatr 1925, 16:36-55.
22. Eguchi K., Satoh T. Characterization of the neurons in the region of solitary tract nucleus during sleep. Physiol Behav 1980, 24(1):99-102.
23. Anaclet C., Ferrari L., Arrigoni E., et al. The GABAergic parafacial zone is a medullary slow wave sleep-promoting center. Nat Neurosci 2014, 17(9):1217-1224.
24. Anaclet C., Lin J.S., Vetrivelan R., et al. Identification and characterization of a sleep-active cell group in the rostral medullary brainstem. J Neurosci 2012, 32(50):17970-17976.
25. Fuller P.M., Sherman D., Pedersen N.P., et al. Reassessment of the structural basis of the ascending arousal system. J Comp Neurol 2011, 519(5):933-956.
26. von Economo C. Sleep as a problem of localization. J Nerv Ment Dis 1930, 71(3):249-259.
27. Nauta W.J.H. Hypothalamic regulation of sleep in rats. An experimental study. J Neurophysiol 1946, 9:285-316.
28. McGinty D.J., Sterman M.B. Sleep suppression after basal forebrain lesions in the cat. Science 1968, 160(833):1253-1255.
29. Sterman M.B., Clemente C.D. Forebrain inhibitory mechanisms: sleep patterns induced by basal forebrain stimulation in the behaving cat. Exp Neurol 1962, 6:103-117.
30. Szymusiak R., McGinty D. Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res 1986, 370(1):82-92.
31. Sherin J.E., Shiromani P.J., McCarley R.W., et al. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271(5246):216-219.
32. Szymusiak R., Alam N., Steininger T.L., et al. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998, 803(1-2):178-188.
33. Gong H., Szymusiak R., King J., et al. Sleep-related c-Fos protein expression in the preoptic hypothalamus: effects of ambient warming. Am J Physiol Regul Integr Comp Physiol 2000, 279(6):R2079-R2088.
34. Suntsova N., Szymusiak R., Alam M.N., et al. Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol 2002, 543(Pt 2):665-677.
35. Lu J., Greco M.A., Shiromani P., et al. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000, 20(10):3830-3842.
36. Chou T.C., Bjorkum A.A., Gaus S.E., et al. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002, 22(3):977-990.
37. Lu J., Bjorkum A.A., Xu M., et al. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J Neurosci 2002, 22(11):4568-4576.
38. Uschakov A., Gong H., McGinty D., et al. Efferent projections from the median preoptic nucleus to sleep- and arousal-regulatory nuclei in the rat brain. Neuroscience 2007, 150(1):104-120.
39. Bai D., Renaud L.P. Median preoptic nucleus neurons: an in vitro patch-clamp analysis of their intrinsic properties and noradrenergic receptors in the rat. Neuroscience 1998, 83(3):905-916.
40. Gallopin T., Fort P., Eggermann E., et al. Identification of sleep-promoting neurons in vitro. Nature 2000, 404(6781):992-995.
41. Szymusiak R. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep 1995, 18(6):478-500.
42. Rye D.B., Wainer B.H., Mesulam M.M., et al. Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 1984, 13(3):627-643.
43. Ranson S.W. Somnolence caused by hypothalamic lesions in the monkey. Arch Neurol Psychiatry 1939, 41(1):1-23.
44. Swett C., Hobson J. The effects of posterior hypothalamic lesions on behavioral and electrographic manifestations of sleep and waking in cats. Arch Ital Biol 1968, 106:270-282.
45. Watanabe T., Taguchi Y., Shiosaka S., et al. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984, 295(1):13-25.
46. Parmentier R., Ohtsu H., Djebbara-Hannas Z., et al. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002, 22(17):7695-7711.
47. Anaclet C., Parmentier R., Ouk K., et al. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009, 29(46):14423-14438.
48. Sherin J.E., Elmquist J.K., Torrealba F., et al. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998, 18(12):4705-4721.
49. Schwartz J.C., Arrang J.M., Garbarg M., et al. Histaminergic transmission in the mammalian brain. Physiol Rev 1991, 71(1):1-51.
50. Lin J.S., Sakai K., Vanni-Mercier G., et al. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 1989, 479(2):225-240.
51. Aserinsky E., Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 1953, 118(3062):273-274.
52. Aserinsky E., Kleitman N. Two types of ocular motility occurring in sleep. J Appl Physiol 1955, 8(1):1-10.
53. Dement W., Kleitman N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr Clin Neurophysiol 1957, 9(4):673-690.
54. Jouvet M., Michel F., Courjon J. On a stage of rapid cerebral electrical activity in the course of physiological sleep. C R Seances Soc Biol Fil 1959, 153:1024-1028. [in French].
55. Evarts E.V., Bental E., Bihari B., et al. Spontaneous discharge of single neurons during sleep and waking. Science 1962, 135:726-728.
56. McCarley R.W., Hobson J.A. Cortical unit activity in desynchronized sleep. Science 1970, 167(919):901-903.
57. Siegel J.M., McGinty D.J. Brainstem neurons without spontaneous unit discharge. Science 1976, 193(4249):240-242.
58. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975, 189(4196):55-58.
59. McCarley R.W., Hobson J.A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 1975, 189(4196):58-60.
60. McCarley R.W. Mechanisms and models of REM sleep control. Arch Ital Biol 2004, 142(4):429-467.
61. McCarley R.W., Massaquoi S.G. Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control. J Sleep Res 1992, 1(2):132-137.
62. McCarley R.W. Neurobiology of REM and NREM sleep. Sleep Med 2007, 8(4):302-330.
63. Lu J., Sherman D., Devor M., et al. A putative flip-flop switch for control of REM sleep. Nature 2006, 441(7093):589-594.
64. Luppi P.H., Clement O., Fort P. Paradoxical (REM) sleep genesis by the brainstem is under hypothalamic control. Curr Opin Neurobiol 2013, 23(5):786-792.
65. Siegel J.M., Nienhuis R., Tomaszewski K.S. Rostral brainstem contributes to medullary inhibition of muscle tone. Brain Res 1983, 268(2):344-348.
66. Siegel J.M., Nienhuis R., Tomaszewski K.S. REM sleep signs rostral to chronic transections at the pontomedullary junction. Neurosci Lett 1984, 45(3):241-246.
67. Sastre J.P., Sakai K., Jouvet M. Are the gigantocellular tegmental field neurons responsible for paradoxical sleep?. Brain Res 1981, 229(1):147-161.
68. Katayama Y., DeWitt D.S., Becker D.P., et al. Behavioral evidence for a cholinoceptive pontine inhibitory area: descending control of spinal motor output and sensory input. Brain Res 1984, 296(2):241-262.
69. Steriade M., Datta S., Pare D., et al. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 1990, 10(8):2541-2559.
70. el Mansari M., Sakai K., Jouvet M. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp Brain Res 1989, 76(3):519-529.
71. Kodama T., Takahashi Y., Honda Y. Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem. Neurosci Lett 1990, 114(3):277-282.
72. Greene R.W., Gerber U., McCarley R.W. Cholinergic activation of medial pontine reticular formation neurons in vitro. Brain Res 1989, 476(1):154-159.
73. Brown R.E., Winston S., Basheer R., et al. Electrophysiological characterization of neurons in the dorsolateral pontine rapid-eye-movement sleep induction zone of the rat: intrinsic membrane properties and responses to carbachol and orexins. Neuroscience 2006, 143(3):739-755.
74. Clement O., Sapin E., Libourel P.A., et al. The lateral hypothalamic area controls paradoxical (REM) sleep by means of descending projections to brainstem GABAergic neurons. J Neurosci 2012, 32(47):16763-16774.
75. Jouvet M., Delorme F. Locus coeruleus et sommeil paradoxal. C R Seances Soc Biol Fil 1965, 159:895-899.
76. Henley K., Morrison A.R. A re-evaluation of the effects of lesions of the pontine tegmentum and locus coeruleus on phenomena of paradoxical sleep in the cat. Acta Neurobiol Exp (Wars) 1974, 34(2):215-232.
77. Chase M.H., Soja P.J., Morales F.R. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J Neurosci 1989, 9(3):743-751.
78. Brooks P.L., Peever J.H. Glycinergic and GABA(A)-mediated inhibition of somatic motoneurons does not mediate rapid eye movement sleep motor atonia. J Neurosci 2008, 28(14):3535-3545.
79. Brooks P.L., Peever J.H. Identification of the transmitter and receptor mechanisms responsible for REM sleep paralysis. J Neurosci 2012, 32(29):9785-9795.
80. Krenzer M., Anaclet C., Vetrivelan R., et al. Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One 2011, 6(10):e24998.
81. Schenck C.H., Bundlie S.R., Patterson A.L., et al. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 1987, 257(13):1786-1789.
82. Boeve B.F., Silber M.H., Saper C.B., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130(Pt 11):2770-2788.
83. McCarter S.J., St Louis E.K., Boeve B.F. REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease. Curr Neurol Neurosci Rep 2012, 12(2):182-192.
84. Burgess C.R., Oishi Y., Mochizuki T., et al. Amygdala lesions reduce cataplexy in orexin knock-out mice. J Neurosci 2013, 33(23):9734-9742.
85. Oishi Y., Williams R.H., Agostinelli L., et al. Role of the medial prefrontal cortex in cataplexy. J Neurosci 2013, 33(23):9743-9751.
86. Boehme R.E., Baker T.L., Mefford I.N., et al. Narcolepsy: cholinergic receptor changes in an animal model. Life Sci 1984, 34(19):1825-1828.
87. Kilduff T.S., Bowersox S.S., Kaitin K.I., et al. Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep 1986, 9(1 Pt 2):102-106.
88. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98(3):365-376.
89. de Lecea L., Kilduff T.S., Peyron C., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95(1):322-327.
90. Sakurai T., Amemiya A., Ishii M., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(4):573-585.
91. Sakurai T., Amemiya A., Ishii M., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(5):696.
92. Peyron C., Tighe D.K., van den Pol A.N., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18(23):9996-10015.
93. Harrison T.A., Chen C.T., Dun N.J., et al. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett 1999, 273(1):17-20.
94. Kilduff T.S., Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000, 23(8):359-365.
95. Thannickal T., Moore R.Y., Nienhuis R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27(3):469-474.
96. Date Y., Ueta Y., Yamashita H., et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999, 96(2):748-753.
97. Broberger C., De Lecea L., Sutcliffe J.G., et al. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 1998, 402(4):460-474.
98. Elias C.F., Saper C.B., Maratos-Flier E., et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 1998, 402(4):442-459.
99. Nambu T., Sakurai T., Mizukami K., et al. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827(1-2):243-260.
100. van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999, 19(8):3171-3182.
101. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98(4):437-451.
102. Horvath T.L., Peyron C., Diano S., et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 1999, 415(2):145-159.
103. Espana R.A., Reis K.M., Valentino R.J., et al. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 2005, 481(2):160-178.
104. Yoshida K., McCormack S., Espana R.A., et al. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006, 494(5):845-861.
105. Sakurai T., Nagata R., Yamanaka A., et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46(2):297-308.
106. Hagan J.J., Leslie R.A., Patel S., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999, 96(19):10911-10916.
107. Soffin E.M., Evans M.L., Gill C.H., et al. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002, 42(1):127-133.
108. Brown R.E., Sergeeva O., Eriksson K.S., et al. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 2001, 40(3):457-459.
109. Liu R.J., van den Pol A.N., Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 2002, 22(21):9453-9464.
110. Eriksson K.S., Sergeeva O., Brown R.S., et al. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21(23):9273-9279.
111. Bayer L., Eggermann E., Serafin M., et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001, 14(9):1571-1575.
112. Yamanaka A., Tsujino N., Funahashi H., et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002, 290(4):1237-1245.
113. Burlet S., Tyler C.J., Leonard C.S. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002, 22(7):2862-2872.
114. Takahashi K., Koyama Y., Kayama Y., et al. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 2002, 56(3):335-336.
115. Eggermann E., Serafin M., Bayer L., et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001, 108(2):177-181.
116. Borgland S.L., Taha S.A., Sarti F., et al. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49(4):589-601.
117. Korotkova T.M., Sergeeva O.A., Eriksson K.S., et al. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003, 23(1):7-11.
118. van den Pol A.N., Gao X.B., Obrietan K., et al. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998, 18(19):7962-7971.
119. Ivanov A., Aston-Jones G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 2000, 11(8):1755-1758.
120. Hoang Q.V., Bajic D., Yanagisawa M., et al. Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 2003, 90(2):693-702.
121. Hoang Q.V., Zhao P., Nakajima S., et al. Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons. J Neurophysiol 2004, 92(6):3183-3191.
122. Hwang L.L., Chen C.T., Dun N.J. Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 2001, 537(Pt 2):511-520.
123. Yang B., Ferguson A.V. Orexin-A depolarizes dissociated rat area postrema neurons through activation of a nonselective cationic conductance. J Neurosci 2002, 22(15):6303-6308.
124. Yang B., Ferguson A.V. Orexin-A depolarizes nucleus tractus solitarius neurons through effects on nonselective cationic and K+ conductances. J Neurophysiol 2003, 89(4):2167-2175.
125. Yang B., Samson W.K., Ferguson A.V. Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C. J Neurosci 2003, 23(15):6215-6222.
126. Follwell M.J., Ferguson A.V. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 2002, 545(Pt 3):855-867.
127. Smith B.N., Davis S.F., Van Den Pol A.N., et al. Selective enhancement of excitatory synaptic activity in the rat nucleus tractus solitarius by hypocretin 2. Neuroscience 2002, 115(3):707-714.
128. Xi M.C., Fung S.J., Yamuy J., et al. Hypocretinergic facilitation of synaptic activity of neurons in the nucleus pontis oralis of the cat. Brain Res 2003, 976(2):253-258.
129. Davis S.F., Williams K.W., Xu W., et al. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J Neurosci 2003, 23(9):3844-3854.
130. Chou T.C., Lee C.E., Lu J., et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 2001, 21(19):RC168.
131. Hakansson M., de Lecea L., Sutcliffe J.G., et al. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 1999, 11(8):653-663.
132. Risold P.Y., Griffond B., Kilduff T.S., et al. Preprohypocretin (orexin) and prolactin-like immunoreactivity are coexpressed by neurons of the rat lateral hypothalamic area. Neurosci Lett 1999, 259(3):153-156.
133. Torrealba F., Yanagisawa M., Saper C.B. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003, 119(4):1033-1044.
134. Henny P., Brischoux F., Mainville L., et al. Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience 2010, 169(3):1150-1157.
135. Schone C., Apergis-Schoute J., Sakurai T., et al. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 2014, 7(3):697-704.
136. Li Y., Gao X.B., Sakurai T., et al. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002, 36(6):1169-1181.
137. Yamanaka A., Beuckmann C.T., Willie J.T., et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38(5):701-713.
138. Hara J., Gerashchenko D., Wisor J.P., et al. Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons. J Neurosci 2009, 29(12):3705-3714.
139. Yamanaka A., Muraki Y., Tsujino N., et al. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem Biophys Res Commun 2003, 303(1):120-129.
140. Wollmann G., Acuna-Goycolea C., van den Pol A.N. Direct excitation of hypocretin/orexin cells by extracellular ATP at P2X receptors. J Neurophysiol 2005, 94(3):2195-2206.
141. Winsky-Sommerer R., Yamanaka A., Diano S., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating the stress response. J Neurosci 2004, 24(50):11439-11448.
142. Acuna-Goycolea C., van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 2004, 24(37):8141-8152.
143. Tsujino N., Yamanaka A., Ichiki K., et al. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J Neurosci 2005, 25(32):7459-7469.
144. Burdakov D., Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005, 9(4):795-803.
145. Burdakov D., Jensen L.T., Alexopoulos H., et al. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006, 50(5):711-722.
146. Li Y., van den Pol A.N. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005, 25(1):173-183.
147. Muraki Y., Yamanaka A., Tsujino N., et al. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004, 24(32):7159-7166.
148. Yamanaka A., Muraki Y., Ichiki K., et al. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J Neurophysiol 2006, 96(1):284-298.
149. Xie X., Crowder T.L., Yamanaka A., et al. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol 2006, 574(Pt 2):399-414.
150. Estabrooke I.V., McCarthy M.T., Ko E., et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21(5):1656-1662.
151. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25(28):6716-6720.
152. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46(5):787-798.
153. Takahashi K., Lin J.S., Sakai K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 2008, 153(3):860-870.
154. Kiyashchenko L.I., Mileykovskiy B.Y., Maidment N., et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002, 22(13):5282-5286.
155. Salomon R.M., Ripley B., Kennedy J.S., et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 2003, 54(2):96-104.
156. Zeitzer J.M., Buckmaster C.L., Parker K.J., et al. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003, 23(8):3555-3560.
157. Bourgin P., Huitron-Resendiz S., Spier A.D., et al. Hypocretin-1 modulates REM sleep through activation of locus coeruleus neurons. J Neurosci 2000, 20(20):7760-7765.
158. Espana R.A., Baldo B.A., Kelley A.E., et al. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001, 106(4):699-715.
159. Methippara M.M., Alam M.N., Szymusiak R., et al. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000, 11(16):3423-3426.
160. Piper D.C., Upton N., Smith M.I., et al. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000, 12(2):726-730.
161. Xi M., Morales F.R., Chase M.H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001, 901(1-2):259-264.
162. Morairty S.R., Wisor J., Silveira K., et al. The wake-promoting effects of hypocretin-1 are attenuated in old rats. Neurobiol Aging 2011, 32(8):1514-1527.
163. Adamantidis A.R., Zhang F., Aravanis A.M., et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450(7168):420-424.
164. Carter M.E., Adamantidis A., Ohtsu H., et al. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 2009, 29(35):10939-10949.
165. Carter M.E., Brill J., Bonnavion P., et al. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012, 109(39):E2635-E2644.
166. Tsunematsu T., Kilduff T.S., Boyden E.S., et al. Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 2011, 31(29):10529-10539.
167. Tsunematsu T., Tabuchi S., Tanaka K.F., et al. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice. Behav Brain Res 2013, 255:64-74.
168. Vazquez-DeRose J., Schwartz M.D., Nguyen A.T., et al. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain. Brain Struct Funct 2014, [Epub ahead of print].
169. Winrow C.J., Gotter A.L., Cox C.D., et al. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist. J Neurogenet 2011, 25(1-2):52-61.
170. Brisbare-Roch C., Dingemanse J., Koberstein R., et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007, 13(2):150-155.
171. Morairty S.R., Revel F.G., Malherbe P., et al. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PLoS One 2012, 7(7):e39131.
172. Morairty S., Wilk A.J., Lincoln W.U., et al. The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats. Front Neurosci 2014, 8:3.
173. Uslaner J.M., Tye S.J., Eddins D.M., et al. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med 2013, 5(179):179ra144.
174. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998, 50(2 Suppl 1):S16-S22.
175. Mignot E., Tafti M., Dement W.C., et al. Narcolepsy and immunity. Adv Neuroimmunol 1995, 5(1):23-37.
176. Partinen M., Kornum B.R., Plazzi G., et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014, 13(6):600-613.
177. Nishino S., Ripley B., Overeem S., et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355(9197):39-40.
178. Peyron C., Faraco J., Rogers W., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6(9):991-997.
179. Gerashchenko D., Kohls M.D., Greco M.A., et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001, 21(18):7273-7283.
180. Gerashchenko D., Blanco-Centurion C., Greco M.A., et al. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003, 116(1):223-235.
181. Hara J., Beuckmann C.T., Nambu T., et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30(2):345-354.
182. Tabuchi S., Tsunematsu T., Black S.W., et al. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J Neurosci 2014, 34(19):6495-6509.
183. Mochizuki T., Crocker A., McCormack S., et al. Behavioral state instability in orexin knock-out mice. J Neurosci 2004, 24(28):6291-6300.
184. Rechtschaffen A., Gilliland M.A., Bergmann B.M., et al. Physiological correlates of prolonged sleep deprivation in rats. Science 1983, 221(4606):182-184.
185. Borbely A.A. A two process model of sleep regulation. Hum Neurobiol 1982, 1(3):195-204.
186. Daan S., Beersma D.G., Borbely A.A. Timing of human sleep: recovery process gated by a circadian pacemaker. Am J Physiol 1984, 246(2 Pt 2):R161-R183.
187. Yasenkov R., Deboer T. Circadian regulation of sleep and the sleep EEG under constant sleep pressure in the rat. Sleep 2010, 33(5):631-641.
188. Yasenkov R., Deboer T. Interrelations and circadian changes of electroencephalogram frequencies under baseline conditions and constant sleep pressure in the rat. Neuroscience 2011, 180:212-221.
189. Stephan F.K., Zucker I. Circadian rhythms in drinking behavior and locomotor activity are eliminated by suprachiasmatic lesions. Proc Natl Acad Sci U S A 1972, 69(6):1583-1586.
190. Moore R.Y., Eichler V.B. Loss of circadian adrenal corticosterone rhythm following suprachiasmatic nucleus lesion in the rat. Brain Res 1972, 42:201-206.
191. Ralph M.R., Foster R.G., Davis F.C., et al. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990, 247(4945):975-978.
192. Inouye S.-I.T., Kawamura H. Persistence of circadian rhythmicity in a hypothalamic 'island' containing the suprachiasmatic nucleus. Proc Natl Acad Sci U S A 1979, 76:5962-5966.
193. Ibuka N., Inouye S.I., Kawamura H. Analysis of sleep-wakefulness rhythms in male rats after suprachiasmatic nucleus lesions and ocular enucleation. Brain Res 1977, 122(1):33-47.
194. Ibuka N., Kawamura H. Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions. Brain Res 1975, 96(1):76-81.
195. Mouret J., Coindet J., Debilly G., et al. Suprachiasmatic nuclei lesions in the rat: alterations in sleep circadian rhythms. Electroencephalogr Clin Neurophysiol 1978, 45(3):402-408.
196. Tobler I., Borbely A.A., Groos G. The effect of sleep deprivation on sleep in rats with suprachiasmatic lesions. Neurosci Lett 1983, 42(1):49-54.
197. Mistlberger R.E., Bergmann B.M., Waldenar W., et al. Recovery sleep following sleep deprivation in intact and suprachiasmatic nuclei-lesioned rats. Sleep 1983, 6(3):217-233.
198. Easton A., Meerlo P., Bergmann B., et al. The suprachiasmatic nucleus regulates sleep timing and amount in mice. Sleep 2004, 27(7):1307-1318.
199. Edgar D.M., Dement W.C., Fuller C.A. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J Neurosci 1993, 13(3):1065-1079.
200. Larkin J.E., Yokogawa T., Heller H.C., et al. Homeostatic regulation of sleep in arrhythmic Siberian hamsters. Am J Physiol Regul Integr Comp Physiol 2004, 287(1):R104-R111.
201. Mistlberger R.E. Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev 2005, 49(3):429-454.
202. Deboer T., Overeem S., Visser N.A., et al. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 2004, 129(3):727-732.
203. Fujiki N., Yoshida Y., Ripley B., et al. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001, 12(5):993-997.
204. Wu M.F., John J., Maidment N., et al. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 2002, 283(5):R1079-R1086.
205. Deboer T., Detari L., Meijer J.H. Long term effects of sleep deprivation on the mammalian circadian pacemaker. Sleep 2007, 30(3):257-262.
206. Deboer T., Vansteensel M.J., Detari L., et al. Sleep states alter activity of suprachiasmatic nucleus neurons. Nat Neurosci 2003, 6(10):1086-1090.
207. Cambras T., Weller J.R., Angles-Pujoras M., et al. Circadian desynchronization of core body temperature and sleep stages in the rat. Proc Natl Acad Sci U S A 2007, 104(18):7634-7639.
208. Lee M.L., Swanson B.E., de la Iglesia H.O. Circadian timing of REM sleep is coupled to an oscillator within the dorsomedial suprachiasmatic nucleus. Curr Biol 2009, 19(10):848-852.
209. Wurts S.W., Edgar D.M. Circadian and homeostatic control of rapid eye movement (REM) sleep: promotion of REM tendency by the suprachiasmatic nucleus. J Neurosci 2000, 20(11):4300-4310.
210. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418(6901):935-941.
211. Takahashi J.S., Hong H.K., Ko C.H., et al. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008, 9(10):764-775.
212. Dudley C.A., Erbel-Sieler C., Estill S.J., et al. Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice. Science 2003, 301(5631):379-383.
213. Laposky A., Easton A., Dugovic C., et al. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 2005, 28(4):395-409.
214. Naylor E., Bergmann B.M., Krauski K., et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci 2000, 20(21):8138-8143.
215. Shiromani P.J., Xu M., Winston E.M., et al. Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 2004, 287(1):R47-R57.
216. Wisor J.P., O'Hara B.F., Terao A., et al. A role for cryptochromes in sleep regulation. BMC Neurosci 2002, 3:20.
217. Curie T., Maret S., Emmenegger Y., et al. In vivo imaging of the central and peripheral effects of sleep deprivation and suprachiasmatic nuclei lesion on PERIOD-2 protein in mice. Sleep 2015, [Epub ahead of print].
218. Franken P., Thomason R., Heller H.C., et al. A non-circadian role for clock-genes in sleep homeostasis: a strain comparison. BMC Neurosci 2007, 8:87.
219. Mongrain V., La Spada F., Curie T., et al. Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS One 2011, 6(10):e26622.
220. Thompson C.L., Wisor J.P., Lee C.K., et al. Molecular and anatomical signatures of sleep deprivation in the mouse brain. Front Neurosci 2010, 4:165.
221. Wisor J.P., Pasumarthi R.K., Gerashchenko D., et al. Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains. J Neurosci 2008, 28(28):7193-7201.
222. Suntsova N., Guzman-Marin R., Kumar S., et al. The median preoptic nucleus reciprocally modulates activity of arousal-related and sleep-related neurons in the perifornical lateral hypothalamus. J Neurosci 2007, 27(7):1616-1630.
223. Gvilia I., Xu F., McGinty D., et al. Homeostatic regulation of sleep: a role for preoptic area neurons. J Neurosci 2006, 26(37):9426-9433.
224. Gvilia I., Turner A., McGinty D., et al. Preoptic area neurons and the homeostatic regulation of rapid eye movement sleep. J Neurosci 2006, 26(11):3037-3044.
225. Gerashchenko D., Wisor J.P., Burns D., et al. Identification of a population of sleep-active cerebral cortex neurons. Proc Natl Acad Sci U S A 2008, 105(29):10227-10232.
226. Pasumarthi R.K., Gerashchenko D., Kilduff T.S. Further characterization of sleep-active neuronal nitric oxide synthase neurons in the mouse brain. Neuroscience 2010, 169(1):149-157.
227. Vaucher E., Linville D., Hamel E. Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex. Neuroscience 1997, 79(3):827-836.
228. Cauli B., Tong X.K., Rancillac A., et al. Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J Neurosci 2004, 24(41):8940-8949.
229. Tomioka R., Okamoto K., Furuta T., et al. Demonstration of long-range GABAergic connections distributed throughout the mouse neocortex. Eur J Neurosci 2005, 21(6):1587-1600.
230. Tomioka R., Rockland K.S. Long-distance corticocortical GABAergic neurons in the adult monkey white and gray matter. J Comp Neurol 2007, 505(5):526-538.
231. Higo S., Akashi K., Sakimura K., et al. Subtypes of GABAergic neurons project axons in the neocortex. Front Neuroanat 2009, 3:25.
232. Higo S., Udaka N., Tamamaki N. Long-range GABAergic projection neurons in the cat neocortex. J Comp Neurol 2007, 503(3):421-431.
233. Morairty S.R., Dittrich L., Pasumarthi R.K., et al. A role for cortical nNOS/NK1 neurons in coupling homeostatic sleep drive to EEG slow wave activity. Proc Natl Acad Sci U S A 2013, 110(50):20272-20277.
234. Dittrich L., Morairty S.R., Warrier D.R., et al. Homeostatic sleep pressure is the primary factor for activation of cortical nNOS/NK1 neurons. Neuropsychopharmacology 2015, 40(3):632-639.
235. Kilduff T.S., Cauli B., Gerashchenko D. Activation of cortical interneurons during sleep: an anatomical link to homeostatic sleep regulation?. Trends Neurosci 2011, 34(1):10-19.
236. Krueger J.M., Obal F.J., Fang J., et al. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001, 933:211-221.
237. Majde J.A., Krueger J.M. Links between the innate immune system and sleep. J Allergy Clin Immunol 2005, 116(6):1188-1198.
238. Ehlers C.L., Reed T.K., Henriksen S.J. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986, 42(6):467-474.
239. Opp M., Obal F., Krueger J.M. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 1989, 257(3 Pt 2):R528-R535.
240. Chastrette N., Cespuglio R., Jouvet M. Proopiomelanocortin (POMC)-derived peptides and sleep in the rat. Part 1-hypnogenic properties of ACTH derivatives. Neuropeptides 1990, 15(2):61-74.
241. Nishino S., Arrigoni J., Shelton J., et al. Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. J Neurosci 1997, 17(16):6401-6408.
242. Riehl J., Honda K., Kwan M., et al. Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy. Neuropsychopharmacology 2000, 23(1):34-45.
243. Hemmeter U., Rothe B., Guldner J., et al. Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers. Neuropsychobiology 1998, 38(1):25-31.
244. Zini I., Merlo Pich E., Fuxe K., et al. Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle. Acta Physiol Scand 1984, 122(1):71-77.
245. Ehlers C.L., Somes C., Lopez A., et al. Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy?. Neuropsychopharmacology 1997, 17(1):34-43.
246. Szentirmai E., Krueger J.M. Central administration of neuropeptide Y induces wakefulness in rats. Am J Physiol Regul Integr Comp Physiol 2006, 291(2):R473-R480.
247. Antonijevic I.A., Murck H., Bohlhalter S., et al. Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 2000, 39(8):1474-1481.
248. Held K., Antonijevic I., Murck H., et al. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 2006, 31(1):100-107.
249. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43(4):487-497.
250. Huitron-Resendiz S., Kristensen M.P., Sanchez-Alavez M., et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 2005, 25(23):5465-5474.
251. Obal F., Alfoldi P., Cady A.B., et al. Growth hormone-releasing factor enhances sleep in rats and rabbits. Am J Physiol 1988, 255(2 Pt 2):R310-R316.
252. Steiger A. Neurochemical regulation of sleep. J Psychiatr Res 2007, 41(7):537-552.
253. Van Cauter E., Plat L., Scharf M.B., et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. J Clin Invest 1997, 100(3):745-753.
254. Havlicek V., Rezek M., Friesen H. Somatostatin and thyrotropin releasing hormone: central effect on sleep and motor system. Pharmacol Biochem Behav 1976, 4(4):455-459.
255. Rezek M., Havlicek V., Hughes K.R., et al. Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior. Pharmacol Biochem Behav 1976, 5(1):73-77.
256. Szentirmai E., Kapas L., Krueger J.M. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 2007, 292(1):R575-R585.
257. Rojas-Ramirez J.A., Crawley J.N., Mendelson W.B. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin. Neuropeptides 1982, 3(2):129-138.
258. Kapas L., Obal F., Alfoldi P., et al. Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature. Brain Res 1988, 438(1-2):155-164.
259. Kapas L., Obal F., Opp M.R., et al. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits. Physiol Behav 1991, 50(6):1241-1244.
260. Prospero-Garcia O., Ott T., Drucker-Colin R. Cerebroventricular infusion of cholecystokinin (CCK-8) restores REM sleep in parachlorophenylalanine (PCPA)-pretreated cats. Neurosci Lett 1987, 78(2):205-210.
261. Sangiah S., Caldwell D.F., Villeneuve M.J., et al. Sleep: sequential reduction of paradoxical (REM) and elevation of slow-wave (NREM) sleep by a non-convulsive dose of insulin in rats. Life Sci 1982, 31(8):763-769.
262. Danguir J., Nicolaidis S. Chronic intracerebroventricular infusion of insulin causes selective increase of slow wave sleep in rats. Brain Res 1984, 306(1-2):97-103.
263. Obal F., Kapas L., Bodosi B., et al. Changes in sleep in response to intracerebral injection of insulin-like growth factor-1 (IFG-1) in the rat. Sleep Res Online 1998, 1(2):87-91.
264. Verret L., Goutagny R., Fort P., et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 2003, 4:19.
265. Hanriot L., Camargo N., Courau A.C., et al. Characterization of the melanin-concentrating hormone neurons activated during paradoxical sleep hypersomnia in rats. J Comp Neurol 2007, 505(2):147-157.
266. Apergis-Schoute J., Iordanidou P., Faure C., et al. Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits. J Neurosci 2015, 35(14):5435-5441.
267. Parks G.S., Olivas N.D., Ikrar T., et al. Histamine inhibits the melanin-concentrating hormone system: implications for sleep and arousal. J Physiol 2014, 592(Pt 10):2183-2196.
268. Jego S., Glasgow S.D., Herrera C.G., et al. Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus. Nat Neurosci 2013, 16(11):1637-1643.
269. Tsunematsu T., Ueno T., Tabuchi S., et al. Optogenetic manipulation of activity and temporally controlled cell-specific ablation reveal a role for MCH neurons in sleep/wake regulation. J Neurosci 2014, 34(20):6896-6909.
270. Konadhode R.R., Pelluru D., Blanco-Centurion C., et al. Optogenetic stimulation of MCH neurons increases sleep. J Neurosci 2013, 33(25):10257-10263.
271. Roky R., Valatx J.L., Jouvet M. Effect of prolactin on the sleep-wake cycle in the rat. Neurosci Lett 1993, 156(1-2):117-120.
272. Obal F., Opp M., Cady A.B., et al. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits. Brain Res 1989, 490(2):292-300.
273. Riou F., Cespuglio R., Jouvet M. Hypnogenic properties of the vasoactive intestinal polypeptide in rats. C R Seances Acad Sci III 1981, 293(12):679-682. [in French].
274. Fang J., Payne L., Krueger J.M. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats. Brain Res 1995, 686(1):23-28.
275. Aguilar-Roblero R., Verduzco-Carbajal L., Rodriguez C., et al. Circadian rhythmicity in the GABAergic system in the suprachiasmatic nuclei of the rat. Neurosci Lett 1993, 157:199-202.
276. Ahnaou A., Basille M., Gonzalez B., et al. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat. Eur J Neurosci 1999, 11(11):4051-4058.
277. Ahnaou A., Laporte A.M., Ballet S., et al. Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulation. Eur J Neurosci 2000, 12(12):4496-4504.
278. Yanik G., Glaum S., Radulovacki M. The dose-response effects of caffeine on sleep in rats. Brain Res 1987, 403(1):177-180.
279. Benington J.H., Heller H.C. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 1995, 45(4):347-360.
280. Scharf M.T., Naidoo N., Zimmerman J.E., et al. The energy hypothesis of sleep revisited. Prog Neurobiol 2008, 86(3):264-280.
281. Dunwiddie T.V., Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1982, 220(1):70-76.
282. Feldberg W., Sherwood S.L. Injections of drugs into the lateral ventricle of the cat. J Physiol 1954, 123(1):148-167.
283. Radulovacki M., Virus R.M., Djuricic-Nedelson M., et al. Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 1984, 228(2):268-274.
284. Radulovacki M., Virus R.M., Rapoza D., et al. A comparison of the dose response effects of pyrimidine ribonucleosides and adenosine on sleep in rats. Psychopharmacology 1985, 87(2):136-140.
285. Benington J.H., Kodali S.K., Heller H.C. Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res 1995, 692(1-2):79-85.
286. Bjorness T.E., Kelly C.L., Gao T., et al. Control and function of the homeostatic sleep response by adenosine A1 receptors. J Neurosci 2009, 29(5):1267-1276.
287. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001, 24:31-55.
288. Huang Z.L., Qu W.M., Eguchi N., et al. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 2005, 8(7):858-859.
289. Urade Y., Eguchi N., Qu W.M., et al. Sleep regulation in adenosine A2A receptor-deficient mice. Neurology 2003, 61(11 Suppl 6):S94-S96.
290. Porkka-Heiskanen T., Strecker R.E., McCarley R.W. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 2000, 99(3):507-517.
291. Porkka-Heiskanen T., Strecker R.E., Thakkar M., et al. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997, 276(5316):1265-1268.
292. Blanco-Centurion C., Xu M., Murillo-Rodriguez E., et al. Adenosine and sleep homeostasis in the basal forebrain. J Neurosci 2006, 26(31):8092-8100.
293. Kalinchuk A.V., McCarley R.W., Stenberg D., et al. The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions. Neuroscience 2008, 157(1):238-253.
294. Strecker R.E., Morairty S., Thakkar M.M., et al. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res 2000, 115(2):183-204.
295. Kalinchuk A.V., Lu Y., Stenberg D., et al. Nitric oxide production in the basal forebrain is required for recovery sleep. J Neurochem 2006, 99(2):483-498.
296. Kalinchuk A.V., McCarley R.W., Porkka-Heiskanen T., et al. The time course of adenosine, nitric oxide (NO) and inducible NO synthase changes in the brain with sleep loss and their role in the non-rapid eye movement sleep homeostatic cascade. J Neurochem 2011, 116(2):260-272.
297. Kalinchuk A.V., Porkka-Heiskanen T., McCarley R.W., et al. Cholinergic neurons of the basal forebrain mediate biochemical and electrophysiological mechanisms underlying sleep homeostasis. Eur J Neurosci 2015, 41(2):182-195.
298. Halassa M.M., Florian C., Fellin T., et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61(2):213-219.
299. Schmitt L.I., Sims R.E., Dale N., et al. Wakefulness affects synaptic and network activity by increasing extracellular astrocyte-derived adenosine. J Neurosci 2012, 32(13):4417-4425.
300. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J Exp Biol 2006, 209(Pt 12):2304-2311.
301. Petit J.M., Gyger J., Burlet-Godinot S., et al. Genes involved in the astrocyte-neuron lactate shuttle (ANLS) are specifically regulated in cortical astrocytes following sleep deprivation in mice. Sleep 2013, 36(10):1445-1458.
302. Petit J.M., Tobler I., Allaman I., et al. Sleep deprivation modulates brain mRNAs encoding genes of glycogen metabolism. Eur J Neurosci 2002, 16(6):1163-1167.
303. Lewy A.J. Melatonin and human chronobiology. Cold Spring Harb Symp Quant Biol 2007, 72:623-636.
304. Onoe H., Ueno R., Fujita I., et al. Prostaglandin D2, a cerebral sleep-inducing substance in monkeys. Proc Natl Acad Sci U S A 1988, 85(11):4082-4086.
305. Matsumura H., Takahata R., Hayaishi O. Inhibition of sleep in rats by inorganic selenium compounds, inhibitors of prostaglandin D synthase. Proc Natl Acad Sci U S A 1991, 88(20):9046-9050.
306. Takahata R., Matsumura H., Kantha S.S., et al. Intravenous administration of inorganic selenium compounds, inhibitors of prostaglandin D synthase, inhibits sleep in freely moving rats. Brain Res 1993, 623(1):65-71.
307. Qu W.M., Huang Z.L., Xu X.H., et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc Natl Acad Sci U S A 2006, 103(47):17949-17954.
308. Pandey H.P., Ram A., Matsumura H., et al. Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. Biochem Mol Biol Int 1995, 37(3):431-437.
309. Ram A., Pandey H.P., Matsumura H., et al. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. Brain Res 1997, 751(1):81-89.
310. Gerashchenko D., Beuckmann C.T., Kanaoka Y., et al. Dominant expression of rat prostanoid DP receptor mRNA in leptomeninges, inner segments of photoreceptor cells, iris epithelium, and ciliary processes. J Neurochem 1998, 71(3):937-945.
311. Matsumura H., Nakajima T., Osaka T., et al. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc Natl Acad Sci U S A 1994, 91(25):11998-12002.
312. Satoh S., Matsumura H., Suzuki F., et al. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc Natl Acad Sci U S A 1996, 93(12):5980-5984.
313. Mong J.A., Baker F.C., Mahoney M.M., et al. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. J Neurosci 2011, 31(45):16107-16116.
314. Zhang B., Wing Y.K. Sex differences in insomnia: a meta-analysis. Sleep 2006, 29(1):85-93.
315. Armitage R., Hoffmann R., Trivedi M., et al. Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 2000, 95(3):201-213.
316. Dijk D.J., Beersma D.G., Bloem G.M. Sex differences in the sleep EEG of young adults: visual scoring and spectral analysis. Sleep 1989, 12(6):500-507.
317. Manber R., Armitage R. Sex, steroids, and sleep: a review. Sleep 1999, 22(5):540-555.
318. Mourtazaev M.S., Kemp B., Zwinderman A.H., et al. Age and gender affect different characteristics of slow waves in the sleep EEG. Sleep 1995, 18(7):557-564.
319. Armitage R., Hoffmann R.F. Sleep EEG, depression and gender. Sleep Med Rev 2001, 5(3):237-246.
320. Driver H.S., Dijk D.J., Werth E., et al. Sleep and the sleep electroencephalogram across the menstrual cycle in young healthy women. J Clin Endocrinol Metab 1996, 81(2):728-735.
321. Baker F.C., Driver H.S., Paiker J., et al. Acetaminophen does not affect 24-h body temperature or sleep in the luteal phase of the menstrual cycle. J Appl Physiol 2002, 92(4):1684-1691.
322. Shechter A., Varin F., Boivin D.B. Circadian variation of sleep during the follicular and luteal phases of the menstrual cycle. Sleep 2010, 33(5):647-656.
323. Fang J., Fishbein W. Sex differences in paradoxical sleep: influences of estrus cycle and ovariectomy. Brain Res 1996, 734(1-2):275-285.
324. Franken P., Dudley C.A., Estill S.J., et al. NPAS2 as a transcriptional regulator of non-rapid eye movement sleep: genotype and sex interactions. Proc Natl Acad Sci U S A 2006, 103(18):7118-7123.
325. Koehl M., Battle S., Meerlo P. Sex differences in sleep: the response to sleep deprivation and restraint stress in mice. Sleep 2006, 29(9):1224-1231.
326. Paul K.N., Dugovic C., Turek F.W., et al. Diurnal sex differences in the sleep-wake cycle of mice are dependent on gonadal function. Sleep 2006, 29(9):1211-1223.
327. Paul K.N., Laposky A.D., Turek F.W. Reproductive hormone replacement alters sleep in mice. Neurosci Lett 2009, 463(3):239-243.
328. Yamaoka S. Modification of circadian sleep rhythms by gonadal steroids and the neural mechanisms involved. Brain Res 1980, 185(2):385-398.
329. Colvin G.B., Whitmoyer D.I., Lisk R.D., et al. Changes in sleep-wakefulness in female rats during circadian and estrous cycles. Brain Res 1968, 7(2):173-181.
330. Colvin G.B., Whitmoyer D.I., Sawyer C.H. Circadian sleep-wakefulness patterns in rats after ovariectomy and treatment with estrogen. Exp Neurol 1969, 25(4):616-625.
331. Hadjimarkou M.M., Benham R., Schwarz J.M., et al. Estradiol suppresses rapid eye movement sleep and activation of sleep-active neurons in the ventrolateral preoptic area. Eur J Neurosci 2008, 27(7):1780-1792.
332. Deurveilher S., Rusak B., Semba K. Estradiol and progesterone modulate spontaneous sleep patterns and recovery from sleep deprivation in ovariectomized rats. Sleep 2009, 32(7):865-877.
333. Schwartz M.D., Mong J.A. Estradiol suppresses recovery of REM sleep following sleep deprivation in ovariectomized female rats. Physiol Behav 2011, 104(5):962-971.
334. Schwartz M.D., Mong J.A. Estradiol modulates recovery of REM sleep in a time-of-day-dependent manner. Am J Physiol Regul Integr Comp Physiol 2013, 305(3):R271-R280.
335. Cusmano D.M., Hadjimarkou M.M., Mong J.A. Gonadal steroid modulation of sleep and wakefulness in male and female rats is sexually differentiated and neonatally organized by steroid exposure. Endocrinology 2014, 155(1):204-214.
336. Ehlen J.C., Hesse S., Pinckney L., et al. Sex chromosomes regulate nighttime sleep propensity during recovery from sleep loss in mice. PLoS One 2013, 8(5):e62205.
337. Mong J.A., Devidze N., Frail D.E., et al. Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: evidence from high-density oligonucleotide arrays and in situ hybridization. Proc Natl Acad Sci U S A 2003, 100(1):318-323.
338. Silveyra P., Catalano P.N., Lux-Lantos V., et al. Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal. Am J Physiol Endocrinol Metab 2007, 292(3):E820-E828.
339. Silveyra P., Cataldi N.I., Lux-Lantos V., et al. Gonadal steroids modulated hypocretin/orexin type-1 receptor expression in a brain region, sex and daytime specific manner. Regul Pept 2009, 158(1-3):121-126.